Browsed by
Category: Press Releases

Facility Logix Highlights Firm’s Significant Growth as It Celebrates 15th Anniversary

Facility Logix Highlights Firm’s Significant Growth as It Celebrates 15th Anniversary

Facility Logix, a Maryland-based life sciences consulting firm providing best-in-class customized facility solutions and novel approaches to facility design, real estate construction and project management, announced today its 15-year anniversary on the heels of completing a major project for a Southeast medical center and Maryland-based United Therapeutics. The firm served as Owner’s Representative for the new 75,000-square-foot discovery and innovation Building in Jacksonville, Florida. The facility was developed in collaboration with Lung Biotechnology PBC, a subsidiary of United Therapeutics Corporation, and includes three ex-vivo lung perfusion suites and collaborative space for conducting cell-based therapy production, as well as an innovative Life Sciences Incubator that connects entrepreneurs with resources to bring medical solutions to market. ...  Read more

Intrexon to Participate in 2019 BIO International Convention

Intrexon to Participate in 2019 BIO International Convention

GERMANTOWN, Md.May 28, 2019 /PRNewswire/ — Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced the Company and its subsidiaries will participate in the 2019 BIO International Convention June 3-6th in Philadelphia. ...  Read more

Vision Technologies Raises Nearly $50K for Cancer from Golf Tournament

Vision Technologies Raises Nearly $50K for Cancer from Golf Tournament

GLEN BURNIE, MD, May 13, 2019 – Vision Technologies, Inc. (Vision), a leading systems integrator with national and global reach, raised nearly $50,000 for Stand Up To Cancer at its 2019 Charity Golf Outing and Design-Build Showcase this week. Each year, Vision selects a charity for its Making Giving a Reality campaign. Stand Up To Cancer (SU2C) was chosen as the charity for Vision to support during 2019. This organization enables scientific breakthroughs by funding collaborative, multidisciplinary, multi-institutional scientific research teams and investigators. ...  Read more

FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture

FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture

One in Two Women in the United States Will Suffer a Fracture in Her Lifetime Due to Osteoporosis(1)
EVENITY is the First and Only Bone Builder With a Dual Effect That Both Increases Bone Formation and Decreases Bone Loss(2)
EVENITY Rapidly Reduces Fracture Risk and Builds New Bone With 12 Months of Therapy(2)
 ...  Read more